St. Petersburg, Florida: MediNcrease Health Plans, LLC (MediNcrease), a national provider network and provider advocacy firm, is pleased to announce the addition of Myriad Genetics and Crescendo Bioscience to its national provider network. MediNcrease clients and payers will benefit from this contractual arrangement with Myriad. “We are thrilled to welcome Myriad, a leader in the personalized medicine industry with innovative, high-quality molecular diagnostics, to the MediNcrease provider network”, said Christian Clark, MediNcrease’s President and Chief Marketing Officer. “This exciting relationship affirms continued commitment to our specialty laboratories network expansion.”
About Myriad Genetics
Myriad Genetics is a leading molecular diagnostic company dedicated to making a difference in patients’ lives through the discovery and commercialization of transformative tests to assess a person’s risk of developing disease, guide treatment decisions, and assess risk of disease progression and recurrence. Myriad is focused on strategic initiatives to grow existing markets, diversify through the introduction of new products, including companion diagnostics, and expand internationally. For more information on how Myriad is making a difference, please visit the Company’s website: www.myriad.com →
Myriad, the Myriad logo, BART, BRACAnalysis, Colaris, Colaris AP, myPath, myRisk, myRisk Hereditary Cancer, myChoice, myPlan Lung Cancer, BRACAnalysis CDx, HRD, Vectra and Prolaris are trademarks or registered trademarks of Myriad Genetics, Inc. in the United States and foreign countries. MYGN-F, MYGN-G.
About Crescendo Bioscience
Crescendo Bioscience, a wholly-owned subsidiary of Myriad Genetics, Inc., is a molecular diagnostics company dedicated to developing and commercializing quantitative blood tests for rheumatoid arthritis (RA) and other autoimmune diseases, located in South San Francisco, California. Crescendo Bioscience develops quantitative, objective, blood tests to provide rheumatologists with deeper clinical insight to help enable more effective management of patients with autoimmune and inflammatory diseases. For more information, please visit the company’s website at: www.CrescendoBio.com →
About MediNcrease Health Plans
MediNcrease is a uniquely positioned national provider network and provider advocacy firm servicing the commercial health, workers’ compensation and auto medical markets. Our advanced provider network and negotiation solutions not only help facilitate millions of dollars in expedited payments to providers each year, but also provide medical payers with dramatically improved savings and service over traditional PPO networks. The result is a 100% defensible and transparent solution for both providers and payers.
MediNcrease Media Contact:
Chris Vaughn, Marketing Manager
Phone (855) 369-3923
[email protected]
Myriad and Crescendo Media Contact:
Ron Rogers, EVP Corporate Communications
Phone: (801) 584-3065
[email protected]